Latest Trials Latest NewsFAQ

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

Phase 2

Completed

Conditions: Colorectal Cancer
Pancreatic Cancer
Lung Cancer

Interventions: Drug: Vitamin C

First Posted Date: 2017-05-10

Last Posted Date: 2024-05-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 61

Registration Number: NCT03146962

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States

Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block

Phase 4

Completed

Conditions: Surgery of Right Upper Extremity

Interventions: Diagnostic Test: Ultrasound Imaging
Drug: Supraclavicular Block
Other: Bedside Negative Inspiratory Force Meter

First Posted Date: 2017-05-03

Last Posted Date: 2020-05-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 24

Registration Number: NCT03138577

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth

Not Applicable

Terminated

Conditions: Social Anxiety
Social Anxiety Disorder of Childhood
Social Anxiety Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy with Virtual Reality Technology

First Posted Date: 2017-05-02

Last Posted Date: 2022-03-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 19

Registration Number: NCT03135990

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

PRISM 2.0 in Diverse Living Contexts

Not Applicable

Completed

Conditions: Social Isolation in Older Adults

Interventions: Behavioral: Tablet Condition
Behavioral: PRISM 2.0 Condition

First Posted Date: 2017-04-17

Last Posted Date: 2022-07-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 248

Registration Number: NCT03116399

Locations: 🇺🇸
Florida State University, Tallahassee, Florida, United States
🇺🇸
Georgia Institute of Technology, Atlanta, Georgia, United States
🇺🇸
University of Miami, Miami, Florida, United States

and more 1 locations

A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers

Phase 2

Terminated

Conditions: Metastatic Renal Cell Carcinoma
Metastatic Urothelial Carcinoma

Interventions: Drug: Nivolumab
Drug: Atezolizumab
Drug: Pembrolizumab
Radiation: Radiation & immunotherapy

First Posted Date: 2017-04-14

Last Posted Date: 2021-09-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 6

Registration Number: NCT03115801

Locations: 🇺🇸
Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York, United States

Mitochondrial DNA as a Biomarker of Sepsis Severity

Completed

Conditions: Severe Sepsis
Infection
Sepsis Syndrome
Sepsis
Septic Shock

First Posted Date: 2017-03-13

Last Posted Date: 2023-02-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1304

Registration Number: NCT03077672

Locations: 🇺🇸
New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
New York Presbyterian/Weill Cornell Medicine, New York, New York, United States

Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia

Completed

Conditions: Schizophrenia and Related Disorders

First Posted Date: 2017-03-09

Last Posted Date: 2019-01-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1

Registration Number: NCT03075202

Locations: 🇺🇸
Clinical and Translational Science Center, Weill Cornell Medicine, 525 E 68th Street, F-260, New York, New York, United States

A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms

Phase 2

Completed

Conditions: Myeloproliferative Neoplasms

Interventions: Drug: SGI-110

First Posted Date: 2017-03-09

Last Posted Date: 2022-05-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 22

Registration Number: NCT03075826

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Endoscopic Resection Multicenter Registry

Conditions: Gastrointestinal Neoplasms
Neoplasms
Esophageal Neoplasms
Duodenal Polyp
Stomach Neoplasm
Gastric Cancer
Gastric Neoplasm
Gastrointestinal Disease
Duodenal Neoplasms
Stomach Polyp

Interventions: Procedure: Endoscopic Resection

First Posted Date: 2017-02-27

Last Posted Date: 2017-04-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT03065257

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

EUS BD vs ERCP TP for Pancreatic Cancer

Not Applicable

Conditions: Biliary Duct Obstruction
Periampullary Cancer
Unresectable Pancreatic Cancer
Periampullary Carcinoma Non-Resectable
Pancreatic Cancer
Pancreatic Adenocarcinoma
Biliary Tract Neoplasms

Interventions: Procedure: ERCP
Procedure: Endoscopic Ultrasound Guided Biliary Drainage

First Posted Date: 2017-02-24

Last Posted Date: 2017-02-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 120

Registration Number: NCT03063554

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy